Analyst consensus rating
Guardant Health Analyst Rating: Strong Buy
GH is rated Strong Buy by 24 analysts with a $194.29 target. As of 2026-08-26.
Direct answer
Guardant Health's consensus rating is Strong Buy.
24 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $194.29.
Forecast evidence checked August 26, 2026.
Get free Guardant Health email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $170.63
- Average price target
- $194.29
- High price target
- $225.00
- Low price target
- $105.00
- Low target gap
- -38.5%
- Target upside
- +13.9%
- High target gap
- +31.9%
- Target range width
- 70.3%
- Consensus rating
- Strong Buy
- Analysts
- 24
- Evidence date
- August 26, 2026
- Valid through
- September 2, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Guardant Health?
Guardant Health has a verified Strong Buy consensus. The same dataset has an average price target of $194.29.
How far are Guardant Health's low and high targets from the recorded price?
The low target implies -38.5%, while the high target implies +31.9%.
How many analysts are included in Guardant Health's consensus?
The verified consensus includes 24 analysts.
How is Guardant Health's target upside or downside calculated?
The average target of $194.29 is divided by the recorded price of $170.63, then one is subtracted to produce +13.9%. This does not guarantee a future return.
When was Guardant Health's analyst forecast verified?
The data was verified on 2026-08-26. The dataset is valid through 2026-09-02.